

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of endothelial cell differentiation (GO:0045601) | 9.06541006 |
| 2 | secretion by tissue (GO:0032941) | 8.72222301 |
| 3 | regulation of sequestering of triglyceride (GO:0010889) | 8.37131108 |
| 4 | negative regulation of execution phase of apoptosis (GO:1900118) | 8.36021578 |
| 5 | response to phenylpropanoid (GO:0080184) | 8.10848259 |
| 6 | intestinal cholesterol absorption (GO:0030299) | 7.95994494 |
| 7 | cholesterol catabolic process (GO:0006707) | 7.93591418 |
| 8 | sterol catabolic process (GO:0016127) | 7.93591418 |
| 9 | body fluid secretion (GO:0007589) | 7.36357162 |
| 10 | regulation of phospholipid biosynthetic process (GO:0071071) | 6.73127200 |
| 11 | mammary gland epithelial cell differentiation (GO:0060644) | 6.54000070 |
| 12 | valine metabolic process (GO:0006573) | 6.36754345 |
| 13 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 6.25340847 |
| 14 | phospholipid homeostasis (GO:0055091) | 6.24704767 |
| 15 | positive regulation of lipid storage (GO:0010884) | 6.23319459 |
| 16 | ectoderm development (GO:0007398) | 6.15590463 |
| 17 | intestinal absorption (GO:0050892) | 5.58972850 |
| 18 | negative regulation of endothelial cell proliferation (GO:0001937) | 5.32951935 |
| 19 | ceramide catabolic process (GO:0046514) | 5.13870415 |
| 20 | negative regulation of protein kinase B signaling (GO:0051898) | 4.99816704 |
| 21 | positive regulation of osteoblast proliferation (GO:0033690) | 4.72463366 |
| 22 | mitochondrial calcium ion transport (GO:0006851) | 4.67163019 |
| 23 | acyl-CoA biosynthetic process (GO:0071616) | 4.39838085 |
| 24 | thioester biosynthetic process (GO:0035384) | 4.39838085 |
| 25 | acetyl-CoA metabolic process (GO:0006084) | 4.32063940 |
| 26 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.25792858 |
| 27 | lipid storage (GO:0019915) | 4.21878245 |
| 28 | regulation of apoptotic cell clearance (GO:2000425) | 4.19292489 |
| 29 | oligosaccharide metabolic process (GO:0009311) | 4.11315239 |
| 30 | GDP-mannose metabolic process (GO:0019673) | 4.02818676 |
| 31 | negative regulation of lipid catabolic process (GO:0050995) | 3.99022058 |
| 32 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.98440181 |
| 33 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.98318090 |
| 34 | glutathione biosynthetic process (GO:0006750) | 3.93792286 |
| 35 | response to host immune response (GO:0052572) | 3.92314877 |
| 36 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.92314877 |
| 37 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.79941471 |
| 38 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 3.74654611 |
| 39 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.71396515 |
| 40 | regulation of interleukin-13 production (GO:0032656) | 3.70164240 |
| 41 | tricarboxylic acid metabolic process (GO:0072350) | 3.67774643 |
| 42 | negative regulation of epithelial cell differentiation (GO:0030857) | 3.67088940 |
| 43 | positive regulation of reactive oxygen species metabolic process (GO:2000379) | 3.65872671 |
| 44 | steroid catabolic process (GO:0006706) | 3.63223319 |
| 45 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.61953458 |
| 46 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.55053850 |
| 47 | triglyceride biosynthetic process (GO:0019432) | 3.51263266 |
| 48 | response to host (GO:0075136) | 3.46514813 |
| 49 | response to host defenses (GO:0052200) | 3.46514813 |
| 50 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.46514813 |
| 51 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.42982088 |
| 52 | acrosome assembly (GO:0001675) | 3.40623367 |
| 53 | regulation of execution phase of apoptosis (GO:1900117) | 3.35677037 |
| 54 | cellular carbohydrate biosynthetic process (GO:0034637) | 3.33352511 |
| 55 | galactose metabolic process (GO:0006012) | 3.32902558 |
| 56 | regulation of fatty acid oxidation (GO:0046320) | 3.31467199 |
| 57 | acylglycerol biosynthetic process (GO:0046463) | 3.31356721 |
| 58 | neutral lipid biosynthetic process (GO:0046460) | 3.31356721 |
| 59 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.26819414 |
| 60 | phagocytosis, recognition (GO:0006910) | 3.23110131 |
| 61 | branched-chain amino acid metabolic process (GO:0009081) | 3.22399887 |
| 62 | branched-chain amino acid catabolic process (GO:0009083) | 3.18917102 |
| 63 | temperature homeostasis (GO:0001659) | 3.18176750 |
| 64 | purine nucleobase metabolic process (GO:0006144) | 3.09474646 |
| 65 | sphingolipid catabolic process (GO:0030149) | 3.07505042 |
| 66 | positive regulation of chemokine secretion (GO:0090197) | 3.06415636 |
| 67 | mitochondrion distribution (GO:0048311) | 3.05246316 |
| 68 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 3.04282262 |
| 69 | regulation of lipid storage (GO:0010883) | 2.95380741 |
| 70 | long-chain fatty acid transport (GO:0015909) | 2.95334101 |
| 71 | biotin metabolic process (GO:0006768) | 2.89561130 |
| 72 | regulation of interleukin-5 production (GO:0032674) | 2.87272907 |
| 73 | regulation of cholesterol storage (GO:0010885) | 2.84810613 |
| 74 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 2.83029036 |
| 75 | negative regulation of cell fate commitment (GO:0010454) | 2.78546247 |
| 76 | short-chain fatty acid metabolic process (GO:0046459) | 2.76213207 |
| 77 | membrane lipid catabolic process (GO:0046466) | 2.73420133 |
| 78 | regulation of chemokine secretion (GO:0090196) | 2.73008956 |
| 79 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.66952221 |
| 80 | peptide biosynthetic process (GO:0043043) | 2.64694235 |
| 81 | pantothenate metabolic process (GO:0015939) | 2.63896466 |
| 82 | angiogenesis involved in wound healing (GO:0060055) | 2.55089660 |
| 83 | coenzyme A metabolic process (GO:0015936) | 2.53193348 |
| 84 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.52614705 |
| 85 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.50891338 |
| 86 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 2.50052678 |
| 87 | ADP metabolic process (GO:0046031) | 2.46006439 |
| 88 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.43968793 |
| 89 | negative regulation of leukocyte migration (GO:0002686) | 2.42671456 |
| 90 | digestive system process (GO:0022600) | 2.42595765 |
| 91 | detection of molecule of bacterial origin (GO:0032490) | 2.38836478 |
| 92 | ethanol oxidation (GO:0006069) | 2.38075517 |
| 93 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 19.8957468 |
| 94 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 17.2685231 |
| 95 | positive regulation of p38MAPK cascade (GO:1900745) | 16.3501018 |
| 96 | nucleobase catabolic process (GO:0046113) | 13.5503378 |
| 97 | oligosaccharide biosynthetic process (GO:0009312) | 13.2358865 |
| 98 | lactation (GO:0007595) | 10.9683068 |
| 99 | regulation of p38MAPK cascade (GO:1900744) | 10.7531418 |
| 100 | regulation of vasculogenesis (GO:2001212) | 10.4935877 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 8.69091927 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.86332979 |
| 3 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 5.76367230 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.40358621 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.31393427 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.15760883 |
| 7 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.53605386 |
| 8 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.39825731 |
| 9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.26342330 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.16165333 |
| 11 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.15752478 |
| 12 | RXR_22108803_ChIP-Seq_LS180_Human | 2.11328438 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.06432449 |
| 14 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.99831283 |
| 15 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.98001523 |
| 16 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.94562004 |
| 17 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.86775408 |
| 18 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 1.85873823 |
| 19 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.69069357 |
| 20 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.69069357 |
| 21 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.68049798 |
| 22 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.67350364 |
| 23 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.65483011 |
| 24 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.59217665 |
| 25 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.56188044 |
| 26 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.52739574 |
| 27 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.51639944 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.46560575 |
| 29 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.46279051 |
| 30 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.43483503 |
| 31 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.39992551 |
| 32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.38757525 |
| 33 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.38325497 |
| 34 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.38108173 |
| 35 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.32195335 |
| 36 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.30768952 |
| 37 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.30719189 |
| 38 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.28969697 |
| 39 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.27927980 |
| 40 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.26898794 |
| 41 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24226658 |
| 42 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.22819639 |
| 43 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.22653907 |
| 44 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.22110095 |
| 45 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.20428547 |
| 46 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19411918 |
| 47 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.19346961 |
| 48 | LDB1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.19212346 |
| 49 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.18460202 |
| 50 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.17601152 |
| 51 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.17226542 |
| 52 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.12570583 |
| 53 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.11440968 |
| 54 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.11050872 |
| 55 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.10387399 |
| 56 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.06350496 |
| 57 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.04533758 |
| 58 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.04168470 |
| 59 | NFYA_21822215_ChIP-Seq_K562_Human | 1.03949806 |
| 60 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.03289011 |
| 61 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.02944001 |
| 62 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.01392019 |
| 63 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00197411 |
| 64 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.00152626 |
| 65 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.00114437 |
| 66 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.98559417 |
| 67 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.98067305 |
| 68 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.96697323 |
| 69 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.96603096 |
| 70 | CBP_21632823_ChIP-Seq_H3396_Human | 0.96185553 |
| 71 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.95842767 |
| 72 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95070928 |
| 73 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93640400 |
| 74 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.93176025 |
| 75 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.92795353 |
| 76 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.91959487 |
| 77 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.90697701 |
| 78 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.89531841 |
| 79 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88713981 |
| 80 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87928731 |
| 81 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.87900068 |
| 82 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.87439333 |
| 83 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.86560672 |
| 84 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86423551 |
| 85 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.86041746 |
| 86 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.86026036 |
| 87 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.84937086 |
| 88 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.84044397 |
| 89 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.83929262 |
| 90 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.83392608 |
| 91 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.83098950 |
| 92 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.81565254 |
| 93 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81318109 |
| 94 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.79961397 |
| 95 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.79656686 |
| 96 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.79279558 |
| 97 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.79053407 |
| 98 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.78103772 |
| 99 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.76879910 |
| 100 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 0.76619306 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000627_abnormal_mammary_gland | 5.64656675 |
| 2 | MP0003718_maternal_effect | 4.74130445 |
| 3 | MP0004130_abnormal_muscle_cell | 3.55835046 |
| 4 | MP0002254_reproductive_system_inflammat | 2.98233049 |
| 5 | MP0001666_abnormal_nutrient_absorption | 2.95506006 |
| 6 | MP0005083_abnormal_biliary_tract | 2.87642025 |
| 7 | MP0001881_abnormal_mammary_gland | 16.5911500 |
| 8 | MP0003959_abnormal_lean_body | 1.90071170 |
| 9 | MP0003936_abnormal_reproductive_system | 1.88449903 |
| 10 | MP0004147_increased_porphyrin_level | 1.81739914 |
| 11 | MP0003011_delayed_dark_adaptation | 1.79673176 |
| 12 | MP0005395_other_phenotype | 1.71476675 |
| 13 | MP0004043_abnormal_pH_regulation | 1.65125037 |
| 14 | MP0005085_abnormal_gallbladder_physiolo | 1.64793356 |
| 15 | MP0005410_abnormal_fertilization | 1.53360734 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 1.46710519 |
| 17 | MP0005645_abnormal_hypothalamus_physiol | 1.44115263 |
| 18 | MP0005636_abnormal_mineral_homeostasis | 1.32795130 |
| 19 | MP0010234_abnormal_vibrissa_follicle | 1.32093400 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.19475116 |
| 21 | MP0003300_gastrointestinal_ulcer | 1.18314105 |
| 22 | MP0000678_abnormal_parathyroid_gland | 1.16991956 |
| 23 | MP0005452_abnormal_adipose_tissue | 1.05410261 |
| 24 | MP0008004_abnormal_stomach_pH | 1.04893642 |
| 25 | MP0005332_abnormal_amino_acid | 1.01139835 |
| 26 | MP0005360_urolithiasis | 0.93408319 |
| 27 | MP0009764_decreased_sensitivity_to | 0.88940537 |
| 28 | MP0005058_abnormal_lysosome_morphology | 0.87593989 |
| 29 | MP0005448_abnormal_energy_balance | 0.84600025 |
| 30 | MP0002078_abnormal_glucose_homeostasis | 0.81723657 |
| 31 | MP0001849_ear_inflammation | 0.81041578 |
| 32 | MP0003252_abnormal_bile_duct | 0.76934254 |
| 33 | MP0002971_abnormal_brown_adipose | 0.74016003 |
| 34 | MP0009765_abnormal_xenobiotic_induced | 0.73629754 |
| 35 | MP0002009_preneoplasia | 0.72153068 |
| 36 | MP0004924_abnormal_behavior | 0.66869536 |
| 37 | MP0005386_behavior/neurological_phenoty | 0.66869536 |
| 38 | MP0000371_diluted_coat_color | 0.66533042 |
| 39 | MP0002896_abnormal_bone_mineralization | 0.66071694 |
| 40 | MP0009643_abnormal_urine_homeostasis | 0.64444686 |
| 41 | MP0005535_abnormal_body_temperature | 0.63516333 |
| 42 | MP0001727_abnormal_embryo_implantation | 0.63122025 |
| 43 | MP0001765_abnormal_ion_homeostasis | 0.61699874 |
| 44 | MP0003566_abnormal_cell_adhesion | 0.58908897 |
| 45 | MP0000490_abnormal_crypts_of | 0.57450220 |
| 46 | MP0005220_abnormal_exocrine_pancreas | 0.56934208 |
| 47 | MP0000003_abnormal_adipose_tissue | 0.56621236 |
| 48 | MP0000377_abnormal_hair_follicle | 0.56523438 |
| 49 | MP0000613_abnormal_salivary_gland | 0.56176862 |
| 50 | MP0001664_abnormal_digestion | 0.54559239 |
| 51 | MP0003172_abnormal_lysosome_physiology | 0.53421896 |
| 52 | MP0002098_abnormal_vibrissa_morphology | 0.51540757 |
| 53 | MP0001984_abnormal_olfaction | 0.50504445 |
| 54 | MP0005365_abnormal_bile_salt | 0.49233671 |
| 55 | MP0003195_calcinosis | 0.48191472 |
| 56 | MP0008770_decreased_survivor_rate | 0.47568693 |
| 57 | MP0003953_abnormal_hormone_level | 0.47163899 |
| 58 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.46478968 |
| 59 | MP0005334_abnormal_fat_pad | 0.45370413 |
| 60 | MP0002970_abnormal_white_adipose | 0.42950412 |
| 61 | MP0008260_abnormal_autophagy | 0.41994578 |
| 62 | MP0009763_increased_sensitivity_to | 0.41848059 |
| 63 | MP0002135_abnormal_kidney_morphology | 0.38987277 |
| 64 | MP0000569_abnormal_digit_pigmentation | 0.38481651 |
| 65 | MP0000858_altered_metastatic_potential | 0.38374345 |
| 66 | MP0002148_abnormal_hypersensitivity_rea | 0.38347360 |
| 67 | MP0000609_abnormal_liver_physiology | 0.38207488 |
| 68 | MP0010352_gastrointestinal_tract_polyps | 0.36678416 |
| 69 | MP0009642_abnormal_blood_homeostasis | 0.36150147 |
| 70 | MP0000759_abnormal_skeletal_muscle | 0.36048107 |
| 71 | MP0001544_abnormal_cardiovascular_syste | 0.35489861 |
| 72 | MP0005385_cardiovascular_system_phenoty | 0.35489861 |
| 73 | MP0004858_abnormal_nervous_system | 0.34435601 |
| 74 | MP0002693_abnormal_pancreas_physiology | 0.34425848 |
| 75 | MP0009379_abnormal_foot_pigmentation | 0.34180713 |
| 76 | MP0001764_abnormal_homeostasis | 0.33636377 |
| 77 | MP0001177_atelectasis | 0.33568896 |
| 78 | MP0003690_abnormal_glial_cell | 0.32513799 |
| 79 | MP0001756_abnormal_urination | 0.31901906 |
| 80 | MP0010329_abnormal_lipoprotein_level | 0.30481581 |
| 81 | MP0002089_abnormal_postnatal_growth/wei | 0.27520327 |
| 82 | MP0000639_abnormal_adrenal_gland | 0.27357056 |
| 83 | MP0002796_impaired_skin_barrier | 0.27252116 |
| 84 | MP0004264_abnormal_extraembryonic_tissu | 0.25804884 |
| 85 | MP0003638_abnormal_response/metabolism_ | 0.24680140 |
| 86 | MP0009785_altered_susceptibility_to | 0.24087011 |
| 87 | MP0005174_abnormal_tail_pigmentation | 0.22495877 |
| 88 | MP0003699_abnormal_female_reproductive | 0.21949776 |
| 89 | MP0008874_decreased_physiological_sensi | 0.21943004 |
| 90 | MP0003950_abnormal_plasma_membrane | 0.20491902 |
| 91 | MP0008789_abnormal_olfactory_epithelium | 0.20405217 |
| 92 | MP0000470_abnormal_stomach_morphology | 0.20271131 |
| 93 | MP0005646_abnormal_pituitary_gland | 0.19312746 |
| 94 | MP0004782_abnormal_surfactant_physiolog | 0.19089182 |
| 95 | MP0000367_abnormal_coat/_hair | 0.18895702 |
| 96 | MP0000343_altered_response_to | 0.18841910 |
| 97 | MP0006036_abnormal_mitochondrial_physio | 0.18599023 |
| 98 | MP0000537_abnormal_urethra_morphology | 0.18514344 |
| 99 | MP0002084_abnormal_developmental_patter | 0.17863123 |
| 100 | MP0005501_abnormal_skin_physiology | 0.17726768 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of nucleobase metabolism (HP:0010932) | 8.68969500 |
| 2 | Hyperactive renin-angiotensin system (HP:0000841) | 6.66134904 |
| 3 | Decreased circulating renin level (HP:0003351) | 6.44090618 |
| 4 | Renal salt wasting (HP:0000127) | 5.82540242 |
| 5 | Tubulointerstitial nephritis (HP:0001970) | 4.97752301 |
| 6 | Gout (HP:0001997) | 4.69359390 |
| 7 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.66868667 |
| 8 | Hypokalemic alkalosis (HP:0001949) | 4.30948730 |
| 9 | Thin bony cortex (HP:0002753) | 4.17419578 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.10888732 |
| 11 | Chronic bronchitis (HP:0004469) | 4.06815100 |
| 12 | Nephrolithiasis (HP:0000787) | 4.05534155 |
| 13 | Dysmetric saccades (HP:0000641) | 4.04690135 |
| 14 | Hydronephrosis (HP:0000126) | 3.96679172 |
| 15 | Hyperkalemia (HP:0002153) | 3.82931969 |
| 16 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.78338029 |
| 17 | Epidermoid cyst (HP:0200040) | 3.75297757 |
| 18 | Abnormality of the costochondral junction (HP:0000919) | 3.64176879 |
| 19 | Hyperaldosteronism (HP:0000859) | 3.62111661 |
| 20 | Metaphyseal irregularity (HP:0003025) | 3.21555915 |
| 21 | Myocardial infarction (HP:0001658) | 3.20173543 |
| 22 | Action tremor (HP:0002345) | 3.20108079 |
| 23 | Symptomatic seizures (HP:0011145) | 3.19082545 |
| 24 | Genetic anticipation (HP:0003743) | 3.10508306 |
| 25 | Skin nodule (HP:0200036) | 3.06299571 |
| 26 | Hyponatremia (HP:0002902) | 3.01050582 |
| 27 | Tubular atrophy (HP:0000092) | 2.95175516 |
| 28 | Abnormality of renin-angiotensin system (HP:0000847) | 2.93921314 |
| 29 | Hypotension (HP:0002615) | 2.93636355 |
| 30 | Abnormal tarsal ossification (HP:0008369) | 2.85158345 |
| 31 | Xanthomatosis (HP:0000991) | 2.72536799 |
| 32 | Abnormality of chloride homeostasis (HP:0011422) | 2.71169987 |
| 33 | Flat acetabular roof (HP:0003180) | 2.63586999 |
| 34 | Tubulointerstitial fibrosis (HP:0005576) | 2.60430773 |
| 35 | Nausea (HP:0002018) | 2.57881711 |
| 36 | Slow saccadic eye movements (HP:0000514) | 2.55466112 |
| 37 | Delayed epiphyseal ossification (HP:0002663) | 2.51804307 |
| 38 | Enlarged epiphyses (HP:0010580) | 2.51054095 |
| 39 | Loss of speech (HP:0002371) | 2.47860806 |
| 40 | Hyperglycinemia (HP:0002154) | 2.47607786 |
| 41 | Rickets (HP:0002748) | 2.46300762 |
| 42 | Hyperglycinuria (HP:0003108) | 2.45178317 |
| 43 | Postural tremor (HP:0002174) | 2.44535284 |
| 44 | Abnormality of sodium homeostasis (HP:0010931) | 2.41832052 |
| 45 | Widely patent fontanelles and sutures (HP:0004492) | 2.35778460 |
| 46 | Progressive cerebellar ataxia (HP:0002073) | 2.32712338 |
| 47 | Increased purine levels (HP:0004368) | 2.28930326 |
| 48 | Hyperuricemia (HP:0002149) | 2.28930326 |
| 49 | Intrahepatic cholestasis (HP:0001406) | 2.21453558 |
| 50 | Hyperparathyroidism (HP:0000843) | 2.19391721 |
| 51 | Limb ataxia (HP:0002070) | 2.14901319 |
| 52 | Alkalosis (HP:0001948) | 2.14886924 |
| 53 | Adrenal overactivity (HP:0002717) | 2.13620811 |
| 54 | Metabolic acidosis (HP:0001942) | 2.10373630 |
| 55 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.09982774 |
| 56 | Abnormality of glycine metabolism (HP:0010895) | 2.09982774 |
| 57 | Prostate neoplasm (HP:0100787) | 2.09220721 |
| 58 | Protuberant abdomen (HP:0001538) | 2.04264195 |
| 59 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.03691841 |
| 60 | Hypercholesterolemia (HP:0003124) | 2.02986110 |
| 61 | Optic neuritis (HP:0100653) | 2.02974314 |
| 62 | Retrobulbar optic neuritis (HP:0100654) | 2.02974314 |
| 63 | Abnormal epiphyseal ossification (HP:0010656) | 2.01557707 |
| 64 | Abnormality of purine metabolism (HP:0004352) | 12.8066844 |
| 65 | Nephritis (HP:0000123) | 10.5875594 |
| 66 | Azoospermia (HP:0000027) | 1.99938640 |
| 67 | Postural instability (HP:0002172) | 1.95212910 |
| 68 | Abnormality of the renal cortex (HP:0011035) | 1.94548818 |
| 69 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.92609767 |
| 70 | Abnormality of renal excretion (HP:0011036) | 1.90867378 |
| 71 | Hypokalemia (HP:0002900) | 1.90203412 |
| 72 | Congenital sensorineural hearing impairment (HP:0008527) | 1.88631126 |
| 73 | Hypophosphatemia (HP:0002148) | 1.86461580 |
| 74 | Ketosis (HP:0001946) | 1.86414608 |
| 75 | Flat occiput (HP:0005469) | 1.83110762 |
| 76 | Dysostosis multiplex (HP:0000943) | 1.82627361 |
| 77 | Orchitis (HP:0100796) | 1.81793726 |
| 78 | Elevated alkaline phosphatase (HP:0003155) | 1.79871349 |
| 79 | Ketoacidosis (HP:0001993) | 1.79241321 |
| 80 | Glomerulonephritis (HP:0000099) | 1.78400976 |
| 81 | Abnormality of saccadic eye movements (HP:0000570) | 1.78211264 |
| 82 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.78168680 |
| 83 | Glomerulosclerosis (HP:0000096) | 1.75174676 |
| 84 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.74580107 |
| 85 | Pancreatitis (HP:0001733) | 1.73133329 |
| 86 | Gaze-evoked nystagmus (HP:0000640) | 1.68696394 |
| 87 | Epiphyseal stippling (HP:0010655) | 1.67714464 |
| 88 | Neurodegeneration (HP:0002180) | 1.67608026 |
| 89 | Paraparesis (HP:0002385) | 1.67335035 |
| 90 | Abnormality of the periventricular white matter (HP:0002518) | 1.66259144 |
| 91 | Primary adrenal insufficiency (HP:0008207) | 1.62148487 |
| 92 | Dehydration (HP:0001944) | 1.61120536 |
| 93 | Posterior subcapsular cataract (HP:0007787) | 1.61045806 |
| 94 | Spastic tetraparesis (HP:0001285) | 1.59004391 |
| 95 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.58598240 |
| 96 | Hepatosplenomegaly (HP:0001433) | 1.58593484 |
| 97 | Congenital glaucoma (HP:0001087) | 1.54155135 |
| 98 | Asymmetric septal hypertrophy (HP:0001670) | 1.53087296 |
| 99 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.52703182 |
| 100 | Abnormal auditory evoked potentials (HP:0006958) | 1.52500316 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK19 | 4.23570084 |
| 2 | EPHB1 | 3.70455614 |
| 3 | SIK1 | 3.45240729 |
| 4 | BCKDK | 3.44605603 |
| 5 | TRIB3 | 3.29467453 |
| 6 | EPHA3 | 3.24050757 |
| 7 | ZAP70 | 3.21691555 |
| 8 | PKN2 | 3.09670126 |
| 9 | MAP2K6 | 2.91393044 |
| 10 | ICK | 2.72531989 |
| 11 | NME2 | 2.54759267 |
| 12 | PTK6 | 2.30799763 |
| 13 | OXSR1 | 2.27742659 |
| 14 | CSNK1A1 | 2.20698623 |
| 15 | ARAF | 2.13807296 |
| 16 | EEF2K | 2.07019199 |
| 17 | JAK3 | 1.99101852 |
| 18 | TGFBR2 | 1.90510235 |
| 19 | IGF1R | 1.89715413 |
| 20 | STK38 | 1.86609169 |
| 21 | TESK1 | 1.76630114 |
| 22 | MAP3K9 | 1.61309714 |
| 23 | PIK3CG | 1.54810563 |
| 24 | BMPR2 | 1.46436990 |
| 25 | PINK1 | 1.45350246 |
| 26 | STK38L | 1.43670948 |
| 27 | PRKAA2 | 1.37836119 |
| 28 | IRAK1 | 1.30510645 |
| 29 | PDGFRB | 1.24526922 |
| 30 | FRK | 1.20982226 |
| 31 | JAK2 | 1.19800114 |
| 32 | RET | 1.19728589 |
| 33 | BTK | 1.18778464 |
| 34 | MTOR | 1.16123408 |
| 35 | LRRK2 | 1.15691150 |
| 36 | SCYL2 | 1.11768080 |
| 37 | MOS | 1.10103478 |
| 38 | BRAF | 1.09814186 |
| 39 | KSR2 | 1.08531957 |
| 40 | FER | 0.99022786 |
| 41 | PTK2 | 0.93271304 |
| 42 | PDPK1 | 0.92552607 |
| 43 | NLK | 0.87052630 |
| 44 | CHUK | 0.85867440 |
| 45 | MAP3K6 | 0.83419655 |
| 46 | MAP3K13 | 0.82838214 |
| 47 | STK16 | 0.78620280 |
| 48 | RPS6KB1 | 0.78539133 |
| 49 | PDK1 | 0.78509244 |
| 50 | MAPKAPK5 | 0.71032035 |
| 51 | FGFR4 | 0.67852511 |
| 52 | TAOK3 | 0.67784924 |
| 53 | CSNK2A2 | 0.67413520 |
| 54 | CAMK2D | 0.65243171 |
| 55 | PIM1 | 0.61161201 |
| 56 | STK3 | 0.61053153 |
| 57 | GSK3A | 0.61008803 |
| 58 | PRKCD | 0.57316118 |
| 59 | ALK | 0.56016130 |
| 60 | PRKAA1 | 0.54799614 |
| 61 | PRKCG | 0.54247724 |
| 62 | MAP3K1 | 0.53535200 |
| 63 | TESK2 | 0.53441424 |
| 64 | CAMK2G | 0.49635258 |
| 65 | GRK6 | 0.49226074 |
| 66 | TNK2 | 0.48907908 |
| 67 | SGK3 | 0.47993943 |
| 68 | CAMK2B | 0.47973471 |
| 69 | RIPK4 | 0.46983945 |
| 70 | MAPKAPK3 | 0.46573616 |
| 71 | IRAK4 | 0.44641343 |
| 72 | MAP2K1 | 0.44495790 |
| 73 | MAP2K2 | 0.43699154 |
| 74 | LIMK1 | 0.43240673 |
| 75 | FGFR3 | 0.41454983 |
| 76 | TBK1 | 0.38643296 |
| 77 | LMTK2 | 0.38555280 |
| 78 | JAK1 | 0.37867229 |
| 79 | ERN1 | 0.36997302 |
| 80 | GRK7 | 0.36543498 |
| 81 | IRAK2 | 0.36331830 |
| 82 | GRK1 | 0.35226002 |
| 83 | EIF2AK2 | 0.35071264 |
| 84 | EGFR | 0.34259057 |
| 85 | BMPR1B | 0.33973416 |
| 86 | ILK | 0.33677182 |
| 87 | TAOK2 | 0.32904262 |
| 88 | IRAK3 | 0.31658228 |
| 89 | ACVR1B | 0.31335362 |
| 90 | DYRK2 | 0.30598255 |
| 91 | EIF2AK1 | 0.30433500 |
| 92 | SGK223 | 0.30217178 |
| 93 | SGK494 | 0.30217178 |
| 94 | TAOK1 | 0.29359398 |
| 95 | SMG1 | 0.28036882 |
| 96 | MAPK11 | 0.24814760 |
| 97 | SGK2 | 0.24321479 |
| 98 | CDK5 | 0.24148795 |
| 99 | IKBKE | 0.23944783 |
| 100 | BCR | 0.22923350 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 6.37072889 |
| 2 | Galactose metabolism_Homo sapiens_hsa00052 | 3.25370956 |
| 3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.01413476 |
| 4 | Caffeine metabolism_Homo sapiens_hsa00232 | 13.9293909 |
| 5 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.78631682 |
| 6 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.56164715 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.46482885 |
| 8 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.28179526 |
| 9 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.26503443 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.21038430 |
| 11 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.17829958 |
| 12 | Peroxisome_Homo sapiens_hsa04146 | 1.09937278 |
| 13 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.00904168 |
| 14 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.84568732 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.83720624 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.78300338 |
| 17 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.76567742 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.76077591 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.72709043 |
| 20 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.71318617 |
| 21 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.63813638 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.63315873 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 0.61903912 |
| 24 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.59660632 |
| 25 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.51384233 |
| 26 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.51345471 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.44860013 |
| 28 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.43306478 |
| 29 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.38986921 |
| 30 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32209023 |
| 31 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.31903538 |
| 32 | Carbon metabolism_Homo sapiens_hsa01200 | 0.30213790 |
| 33 | Purine metabolism_Homo sapiens_hsa00230 | 0.29353832 |
| 34 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.28966734 |
| 35 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.28656384 |
| 36 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.28313426 |
| 37 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25604887 |
| 38 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.25556033 |
| 39 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.25528030 |
| 40 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21847476 |
| 41 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21837961 |
| 42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.21786754 |
| 43 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.21616976 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.21080739 |
| 45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.20764772 |
| 46 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.18752807 |
| 47 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.18440066 |
| 48 | Salivary secretion_Homo sapiens_hsa04970 | 0.17565594 |
| 49 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.16130022 |
| 50 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.16053280 |
| 51 | Sulfur relay system_Homo sapiens_hsa04122 | 0.15625340 |
| 52 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.15521537 |
| 53 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.15465193 |
| 54 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.14520188 |
| 55 | Pertussis_Homo sapiens_hsa05133 | 0.14039974 |
| 56 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.12126443 |
| 57 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.11904224 |
| 58 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.11087551 |
| 59 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.11010565 |
| 60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.10881116 |
| 61 | Hepatitis C_Homo sapiens_hsa05160 | 0.10365065 |
| 62 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.09634957 |
| 63 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.08522752 |
| 64 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.06291637 |
| 65 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.06066597 |
| 66 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.06065309 |
| 67 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.05821521 |
| 68 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.05596209 |
| 69 | Insulin resistance_Homo sapiens_hsa04931 | 0.05375790 |
| 70 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.05118310 |
| 71 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.05017020 |
| 72 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.04978843 |
| 73 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.04765616 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.03488790 |
| 75 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.03410461 |
| 76 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.03060091 |
| 77 | Lysosome_Homo sapiens_hsa04142 | 0.02799248 |
| 78 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.02307099 |
| 79 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.01896658 |
| 80 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.01015939 |
| 81 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.00533838 |
| 82 | VEGF signaling pathway_Homo sapiens_hsa04370 | -0.0816501 |
| 83 | Complement and coagulation cascades_Homo sapiens_hsa04610 | -0.0807687 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | -0.0695004 |
| 85 | Estrogen signaling pathway_Homo sapiens_hsa04915 | -0.0653153 |
| 86 | mTOR signaling pathway_Homo sapiens_hsa04150 | -0.0643335 |
| 87 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | -0.0635013 |
| 88 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | -0.0543506 |
| 89 | Gastric acid secretion_Homo sapiens_hsa04971 | -0.0538946 |
| 90 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.0474583 |
| 91 | Tight junction_Homo sapiens_hsa04530 | -0.0451172 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0428585 |
| 93 | Endocytosis_Homo sapiens_hsa04144 | -0.0412616 |
| 94 | Endometrial cancer_Homo sapiens_hsa05213 | -0.0401052 |
| 95 | Cholinergic synapse_Homo sapiens_hsa04725 | -0.0372117 |
| 96 | GnRH signaling pathway_Homo sapiens_hsa04912 | -0.0315363 |
| 97 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | -0.0109374 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0074524 |
| 99 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0044091 |
| 100 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0006282 |

